Ampicillin
- Product NDC
- 72485-421
- 11-digit product format
- 724850421
- Labeler code
- 72485
- Product ID
- 72485-421_4596759f-66c6-5801-e063-6394a90a9879
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ampicillin
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Armas Pharmaceuticals Inc.
- Application
- ANDA201025
- Marketing category
- ANDA
- Marketing start
- 2023-11-10
- Substance
- AMPICILLIN SODIUM
- Active strength
- 1 g/1
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC], Penicillins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A201025-001 | AMPICILLIN SODIUM | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | ||
| A201025-002 | AMPICILLIN SODIUM | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | ||
| A201025-003 | AMPICILLIN SODIUM | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | |
| A201025-004 | AMPICILLIN SODIUM | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A201025-003 | AP |
| A201025-004 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A201025-001 | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A201025-002 | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A201025-003 | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A201025-004 | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A201025-001 | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A201025-002 | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A201025-003 | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201025-004 | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201025-001 | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A201025-002 | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A201025-003 | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201025-004 | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201025-001 | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201025-002 | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201025-003 | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201025-004 | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201025-001 | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201025-002 | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201025-003 | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201025-004 | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201025-001 | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201025-002 | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201025-003 | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201025-004 | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201025-001 | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201025-002 | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201025-003 | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201025-004 | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201025-001 | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201025-002 | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201025-003 | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201025-004 | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201025-001 | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201025-002 | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201025-003 | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201025-004 | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201025-001 | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201025-002 | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2014-04-09 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201025-003 | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201025-004 | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2014-04-09 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | A201025-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201025-002 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201025-003 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201025-004 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A201025-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A201025-002 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A201025-003 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A201025-004 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A201025-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A201025-002 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A201025-003 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A201025-004 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A201025-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A201025-002 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A201025-003 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A201025-004 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A201025-001 | AP | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A201025-002 | AP | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A201025-003 | AP | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A201025-004 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A201025-001 | AP | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A201025-002 | AP | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A201025-003 | AP | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A201025-004 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A201025-001 | AP | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A201025-002 | AP | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A201025-003 | AP | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A201025-004 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A201025-001 | AP | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A201025-002 | AP | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A201025-003 | AP | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A201025-004 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A201025-001 | AP | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A201025-002 | AP | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A201025-003 | AP | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A201025-004 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A201025-001 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A201025-002 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A201025-003 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A201025-004 | AP | 1 | b00525d2431f… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ampicillin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| AMPICILLIN SODIUM | 1 g/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| JFN36L5S8K | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 34e95c91-3767-493c-8716-38e61e7c6674 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fd9d6ee0-43ae-43c7-aa52-3d5a936186d6 | Product name | 1 | 20250722 |
| 4fe9b92f-7dcd-4058-8def-e75f4dcd5ab3 | Product name | 2 | 20160201 |
| c9385d77-2af7-47a4-bc97-1127e71caf9b | Product name | 3 | 20160201 |
| 05b6b9ae-4ba4-27ee-4c8c-f72b41de3815 | Product name | 5 | 20151207 |
| b353113e-7b3d-4b1f-a286-b96a3a5eac85 | Product name | 3 | 20151026 |
| 8c59be9b-72b0-49e8-b7ef-1a80c10599de | Product name | 3 | 20150316 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72485-421-10 | Ampicillin | 10 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 10 | 3 | |
| 72485-421-10 | Ampicillin | 1 in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 1 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72485-421-10 | EA - Each | 72485-421 | 449f8ee2-0a35-4e17-a200-23da38a117d5 | 1 | 2024-02-14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ampicillin | AMPICILLIN | ONESOURCE SPECIALTY PHARMA LIMITED | 519f2131-79e7-569f-e063-6394a90a2f93 | 2026-02-27 | Warnings, Adverse reactions | 201025 ANDA201025 |
| Ampicillin sodium | AMPICILLIN SODIUM | Medical Purchasing Solutions, LLC | 402e7cc7-5ae8-c113-e063-6394a90aa54a | 2025-10-02 | Warnings, Adverse reactions | 201025 ANDA201025 |
| Ampicillin | AMPICILLIN | Armas Pharmaceuticals Inc. | 34e95c91-3767-493c-8716-38e61e7c6674 | 2025-07-31 | Warnings, Adverse reactions | 201025 ANDA201025 72485-421 |
| Ampicillin sodium | AMPICILLIN | Civica, Inc. | 2fd0f9fa-5b86-42f7-9a9f-767123638d39 | 2025-06-30 | Warnings, Adverse reactions | 201025 ANDA201025 |
| Ampicillin | AMPICILLIN | Medical Purchasing Solutions, LLC | 29675d9c-3248-337a-e063-6294a90a2e20 | 2024-12-16 | Warnings, Adverse reactions | 201025 ANDA201025 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72485-421-10 | 72485042110 | 10 VIAL in 1 CARTON (72485-421-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL | 10 vial | 2023-11-10 | No | No | Current |